Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin B Kim

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Cancer|July 27, 2004
Pilot study of high-dose, concurrent biochemotherapy for advanced melanomaKevin B Kim, Omar Eton, Mary Jo East, et al.
Melanoma Research|October 1, 2010
Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanomaJade Homsi, Agop Y Bedikian, Nicholas E Papadopoulos, et al.
Journal of Cutaneous Pathology|April 25, 2006
Analysis of protein tyrosine kinases expression in the melanoma metastases of patients treated with Imatinib Mesylate (STI571, Gleevec)Doina Ivan, Maria Niveiro, A Hafeez Diwan, et al.
JCO Precision Oncology|February 9, 2022
Significant Clinical Response to a MEK Inhibitor Therapy in a Patient With Metastatic Melanoma Harboring an <i>RAF1</i> FusionKevin B Kim, Thomas Semrad, Alexa B Schrock, et al.
Melanoma Research|September 23, 2010
Phase I safety study of lenalidomide and dacarbazine in patients with metastatic melanoma previously untreated with systemic chemotherapyWen-Jen Hwu, Robert D Knight, Madhavi Patnana, et al.
BMC Cancer|May 13, 2015
Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case reportDae Won Kim, Edelyn Barcena, Urvi N Mehta, et al.
American Journal of Clinical Oncology|June 10, 2009
Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanomaNicholas E Papadopoulos, Agop Bedikian, Sigrid Ring, et al.
Journal of Radiology and Oncology|August 4, 2023
Nanometer-scale distribution of PD-1 in the melanoma tumor microenvironmentColin J Comerci, Dannielle G McCarthy, Mehdi Nosrati, et al.
Melanoma Research|December 3, 2009
The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanomaChan Yoon, Nicholas E Papadopoulos, Luis H Camacho, et al.
JAAD Case Reports|January 4, 2018
Diffuse granulomatous panniculitis associated with anti PD-1 antibody therapyBaijia Jiang, Maria M Patino, Andrew J Gross, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Cancer|July 27, 2004
Pilot study of high-dose, concurrent biochemotherapy for advanced melanomaKevin B Kim, Omar Eton, Mary Jo East, et al.
Melanoma Research|October 1, 2010
Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanomaJade Homsi, Agop Y Bedikian, Nicholas E Papadopoulos, et al.
Journal of Cutaneous Pathology|April 25, 2006
Analysis of protein tyrosine kinases expression in the melanoma metastases of patients treated with Imatinib Mesylate (STI571, Gleevec)Doina Ivan, Maria Niveiro, A Hafeez Diwan, et al.
JCO Precision Oncology|February 9, 2022
Significant Clinical Response to a MEK Inhibitor Therapy in a Patient With Metastatic Melanoma Harboring an <i>RAF1</i> FusionKevin B Kim, Thomas Semrad, Alexa B Schrock, et al.
Melanoma Research|September 23, 2010
Phase I safety study of lenalidomide and dacarbazine in patients with metastatic melanoma previously untreated with systemic chemotherapyWen-Jen Hwu, Robert D Knight, Madhavi Patnana, et al.
BMC Cancer|May 13, 2015
Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case reportDae Won Kim, Edelyn Barcena, Urvi N Mehta, et al.
American Journal of Clinical Oncology|June 10, 2009
Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanomaNicholas E Papadopoulos, Agop Bedikian, Sigrid Ring, et al.
Journal of Radiology and Oncology|August 4, 2023
Nanometer-scale distribution of PD-1 in the melanoma tumor microenvironmentColin J Comerci, Dannielle G McCarthy, Mehdi Nosrati, et al.
Melanoma Research|December 3, 2009
The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanomaChan Yoon, Nicholas E Papadopoulos, Luis H Camacho, et al.
JAAD Case Reports|January 4, 2018
Diffuse granulomatous panniculitis associated with anti PD-1 antibody therapyBaijia Jiang, Maria M Patino, Andrew J Gross, et al.
Pageof 14